Sparta Biomedical Reports Treatment of First Patients with …
WEB4 days ago · The US FDA granted Ormi Breakthrough Device Designation. The impact of knee osteoarthritis cannot be ignored, with a staggering 651 million people worldwide affected by this debilitating condition.
Sparta Biomedical Reports Treatment of First Patients with
WEB4 days ago · MORRISVILLE, N.C., Sept. 17, 2024 /PRNewswire/ -- Sparta Biomedical, a private medical device company focused on osteoarthritis repair solutions, today announced that it has successfully implanted its Ormi device in patients with focal knee lesions as part of its first-in-human clinical trial. The ongoing prospective, multi-center, single-arm ...
Sparta Biomedical Reports Treatment of First Patients with …
WEB5 days ago · Breaking News. Sparta Biomedical Reports Treatment of First Patients with Breakthrough Device, Ormi; Life Spine Announces Published Article on Discectomy Performance During Transforaminal Lumbar ...
Sparta Biomedical implants Ormi device in first-in-human trial
WEB4 days ago · Wed, Sep 18, 2024, 4:32 AM 2 min read. Medical device company Sparta Biomedical has announced the successful implantation of its Ormi device in a first-in-human clinical trial. Designed to treat ...
Sparta Biomedical Closes an Oversubscribed Convertible Round to …
WEBSparta has developed a first-of-its-kind device, Ormi™, to treat knee osteoarthritis. Ormi was granted Breakthrough Device Designation by the US FDA. Sparta is committed to improving motion, reducing pain, and increasing the quality of …
Sparta Biomedical
WEBApr 16, 2024 · Sparta Biomedical's Breakthrough Device, Ormi, to be Featured at the 17th ICRS World Congress on September 10, 2023
Duke Capital Partners
WEBSparta has developed a first-of-its-kind device, Ormi™, to treat knee osteoarthritis. Ormi was granted Breakthrough Device Designation by the US FDA. Sparta is committed to improving motion, reducing pain, and increasing the quality of …
Sparta Biomedical Closes an Oversubscribed Convertible Round to …
WEBSep 12, 2023 · Sparta has developed a first-of-its-kind device, Ormi™, to treat knee osteoarthritis. Ormi was granted Breakthrough Device Designation by the US FDA.
Sparta Biomedical Closes an Oversubscribed ... - Markets Insider
WEBSep 12, 2023 · Sparta has developed a first-of-its-kind device, Ormi™, to treat knee osteoarthritis. Ormi was granted Breakthrough Device Designation by the US FDA.
Regenerative Medicine Emerges as First Option to Treat Joint Pain
WEBNov 7, 2023 · The Galene platform’s first application is in the company’s Ormi implant, a cartilage-mimicking device adhered to a titanium base that is inserted into the knee to replace defective cartilage. The Ormi device received …
Skip to content